Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Global Blood Ther (GBT)

Global Blood Ther (GBT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Global Blood Ther 181 OYSTER POINT BLVD SOUTH SAN FRANCISCO CA 94080 USA

www.gbt.com P: 650-741-7700 F: 650-741-7701

Description:

Global Blood Therapeutics, Inc. is a clinical-stage biopharmaceutical company that develops treatments for underserved patient communities.

Key Statistics

Overview:

Market Capitalization, $K 4,621,431
Enterprise Value, $K 4,183,061
Shares Outstanding, K 67,476
Annual Sales, $ 194,750 K
Annual Net Income, $ -303,090 K
Last Quarter Sales, $ 71,550 K
Last Quarter Net Income, $ -82,470 K
60-Month Beta 0.45
% of Insider Shareholders 4.90%
Float, K 64,170
% Float 95.10%
Short Volume Ratio 0.48

Growth:

1-Year Return 162.21%
3-Year Return 47.20%
5-Year Return 110.41%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth -93.95%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -1.26 on 08/08/22
Latest Earnings Date 11/03/22
Earnings Per Share ttm -5.01
EPS Growth vs. Prev Qtr 0.00%
EPS Growth vs. Prev Year -12.50%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

GBT Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -170.37%
Return-on-Assets % -39.24%
Profit Margin % -155.63%
Debt/Equity 4.92
Price/Sales 23.73
Price/Cash Flow N/A
Price/Book 37.67
Book Value/Share 1.82
Interest Coverage -18.56
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar